The healthcare IT market is highly profitable and McKesson is in a prime position to take a dominant share of the market and reap significant profits.
As generic drugs take the place of branded drugs in the pharmaceutical marketplace, McKesson stands to benefit from higher-margins generic drugs.
McKesson is one of the largest companies (in terms of revenue) in the world, its size and scale will protect it from intense competition or cyclical economic changes.